Corneal Sensitivity Testing Procedure for Ophthalmologic and Optometric Patients

Anat Galor; Nathan Lighthizer

doi:10.3791/66597

JoVE Journal > Medicine

医学

Corneal Sensitivity Testing Procedure for Ophthalmologic and Optometric Patients

Published: August 02, 2024

doi:

10.3791/66597

Anat Galor*^1,2, Nathan Lighthizer*³

¹Bascom Palmer Eye Institute, ²Miami Veterans Administration Medical Center, ³Northeastern State University Oklahoma College of Optometry

Summary

Corneal sensitivity testing provides insight into the health of the corneal nerves and helps diagnose ocular surface diseases. We present a concise protocol to qualitatively assess corneal sensitivity that can be readily used by eye care providers across clinical settings.

Abstract

The cornea is the most densely innervated structure in the human body, making it one of the most sensitive tissues. Changes in corneal nerve sensitivity can be observed in several ocular surface diseases. Nerve sensitivity may be increased, as is often seen in patients with a neuropathic component to ocular pain, or decreased, as is seen in patients with neurotrophic keratitis. Corneal sensitivity testing involves assessing a patient’s reaction to brief corneal stimulation, yields insight into the health of the corneal nerves, and provides diagnostic value for evaluating the health of the nerves and the interplay with the ocular surface. Currently, there is limited published guidance on how to conduct corneal sensitivity testing in a clinical setting. This article presents a protocol for testing corneal sensitivity using easy-to-use, low-cost materials that are readily accessible to eye care providers (either a cotton swab, a piece of dental floss, or a finely tapered tissue). This protocol allows for qualitative assessment of corneal sensitivity in which responses to corneal stimulation are rated from 0 (no response) to 3 (hypersensitive response). This test can be performed quickly (in approximately 30 s). Given its diagnostic value and accessibility, corneal sensitivity testing should be included as part of the standard eye examination for any patient undergoing an ocular surface examination.

Introduction

The main functions of the cornea are to protect the contents of the eye and to focus light on the retina¹. The cornea is the most densely innervated structure in the human body, with 7000 nerve receptors per mm², and, consequently, is one of its most sensitive tissues²^,³. The corneal nerves originate from the ophthalmic branch of the trigeminal nerves and play a key role in maintaining corneal homeostasis and integrity by mediating protective reflexes such as blinking and tear production, providing trophic support to the ocular surface, and stimulating wound healing by releasing neuromediators¹^,⁴^,⁵^,⁶.

Damage with subsequent dysfunction of corneal nerves (hypersensitivity or hyposensitivity) can contribute to ocular surface diseases³^,⁷^,⁸. In fact, neurosensory abnormalities have been recognized as potential contributors to dry eye disease symptoms and signs and were incorporated into the 2017 Tear Film and Ocular Surface definition of dry eye disease: "a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, and accompanied by ocular symptoms, in which tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities play etiological roles⁶^,⁹^,¹⁰." Additionally, injury or dysfunction anywhere along the trigeminal nerve pathway can lead to neurotrophic keratitis (NK)¹¹, a degenerative condition of the cornea; its stages include epithelial keratopathy, ulceration, and perforation, which may result in subsequent vision loss³.

Ocular surface pain can be categorized as nociceptive or neuropathic in origin⁸. In neuropathic ocular surface pain, nerves become hypersensitive because of the effects of a lesion or disease of the somatosensory pathway, which is often caused by maladaptive healing after trauma or surgery⁸. Abnormalities in corneal nerves have also been reported in other eye diseases, including glaucoma, thyroid eye disease, keratoconus, diabetic keratopathy, and Fuch's endothelial dystrophy¹²^,¹³^,¹⁴^,¹⁵, and these findings are reproducible in animal models⁶^,¹⁶^,¹⁷. Notably, nerve abnormalities are not always identified as a component of eye disease, and a neurotrophic or neuropathic component to pain is often missed, underscoring the need for more diagnostic procedures to assess for the presence of nerve abnormalities¹⁸. Since ocular surface diseases may involve or induce corneal nerve dysfunction, a concise technique to assess corneal nerve function provides considerable diagnostic value.

Corneal sensitivity testing assesses a patient's reaction to brief corneal stimulation, providing functional insight into the status of the corneal nerves (absent, reduced, normal, or increased sensitivity)¹³^,¹⁹. For example, in patients with neurotrophic keratitis, studies have found positive relationships between corneal sensitivity and parameters of corneal nerve innervation as assessed using in vivo confocal microscopy²⁰^,²¹, including corneal nerve fiber length (R²= 0.2951, P = 0.0016)²¹. A positive correlation between corneal sensitivity and corneal nerve density has also been observed in herpes simplex keratitis (r = 0.55, P < 0.001) and dry eye disease (r = 0.644; P = 0.045)²²^,²³. However, abnormal corneal innervation does not always correlate with aberrant corneal sensitivity¹³.

Alterations in corneal sensitivity have been reported in dry eye disease (including both Sjögren's dry eye disease and diabetes mellitus-related dry eye disease); ocular neuropathic pain; neurotrophic keratitis; Fuch's endothelial dystrophy; and ocular treatments for glaucoma including topical drops, laser trabeculoplasty, slow coagulation transscleral cyclophotocoagulation, and micropulse ciliary body ablation³^,⁸^,¹²^,²⁴^,²⁵^,²⁶^,²⁷^,²⁸^,²⁹. Additionally, short-term hypoesthesia can be secondary to refractive surgery³⁰. Reduced or absent corneal sensitivity is a hallmark of neurotrophic keratitis and is key to its diagnosis³^,¹¹^,³¹. Reduced corneal sensitivity often presents with low tear production and epithelial disruption, and increased sensitivity can signal ocular neuropathic pain, although neuropathic mechanisms can contribute to pain even in individuals with reduced or normal corneal sensitivity⁹^,³².

Corneal sensitivity can be assessed using either qualitative or quantitative methods, although quantitative methods are primarily limited to research settings²^,⁸^,¹¹^,³¹^,³³^,³⁴^,³⁵. Quantitative assessments are made using either the Cochet-Bonnet esthesiometer or Belmonte's gas esthesiometer; a new non-contact esthesiometer, the Corneal Esthesiometer Brill, was recently registered by both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) for corneal sensitivity testing³⁶^,³⁷^,³⁸^,³⁹. The limitations associated with the Cochet-Bonnet and Belmonte's gas esthesiometers, including the cost and the challenge of maintaining sterility, render their use infrequent in clinical practice³. Qualitative methods can be easily performed by eye care providers or physician extenders, as they are low cost, readily available, and require little training and time⁸^,³³^,³⁷. Furthermore, there is insufficient published guidance on how to conduct corneal sensitivity testing and how corneal sensitivity scores as part of a clinical workup may inform diagnosis. Here, we detail a protocol for corneal sensitivity testing that is cost-effective, easy to comprehend, accessible, and can be readily adopted by eye care providers across clinical settings.

Protocol

This study was approved by the institutional review board of the University of Miami, and the methods adhered to the tenets of the Declaration of Helsinki. All patients signed an informed consent form before participation. The reagents and the equipment used in the study are listed in the Table of Materials.

1. Pre-procedural preparation

Perform corneal sensitivity testing on patients who are suspected of having ocular surface disease with alterations in the corneal nerves (Table 1)¹¹^,³¹^,⁴⁰^,⁴¹^,⁴².
Ensure that testing is conducted before administering any eye drops, particularly anesthetic eye drops, as anesthetic eye drops decrease corneal sensitivity⁴³ for a period (that varies by the type of eye drop used).
Ensure that contact lenses are removed prior to testing.

2. Testing procedure

NOTE: Figure 1 depicts the overview of the testing procedure.

Ask the patient to sit in a comfortable position on a chair.
Use a cotton wisp (from a sterile cotton swab); unwaxed, unflavored dental floss; or a finely tapered tip of tissue as a stimulus for qualitative assessment of corneal sensitivity¹¹^,³³ (Figure 1, step 2).
NOTE: Keep the testing stimulus in each lane for easy access.
Instruct the patient to fixate on a target, such as a point or letter of a test chart that is straight ahead⁴⁴ (Figure 1, step 3).
If the patient presents with one suspected affected eye, test the unaffected cornea first.
NOTE: If a bilateral condition is suspected, first test the less affected cornea.
Ask the patient to report when they feel the stimulus touch their cornea (Figure 1, step 4).
Approach the patient's lateral side to reduce false positive responses caused by the patient reacting to the stimulus prior to contact⁴⁴^,⁴⁵.
Gently bring the stimulus in contact with the center of the cornea and observe the blink reflex, being careful not to touch the eyelids or lashes prior to touching the cornea (Figure 1, step 5).
Record the corneal sensitivity of each eye using a 0-3 scale (Figure 1, step 6): Absent (0), reduced (1), normal (2), or increased/hypersensitive (3) response to stimulus.
To perform a thorough examination, test all quadrants of the cornea³^,¹¹ in clockwise order using a new stimulus (Figure 1, step 5).
NOTE: A single measurement from the center of the cornea is generally sufficient to assess corneal sensitivity. Some patients may not tolerate repeated testing and may request that the provider stop after the center of the cornea is evaluated. However, if atypical sensation is present elsewhere in the cornea, testing only central sensation may lead to an inaccurate diagnosis.
To test the limbus, ask the patient to fixate on a target above the horizontal plane⁴⁴.
Repeat the corneal testing procedure in the contralateral eye using an unused cotton wisp, dental floss, or tissue.

3. Recording the corneal sensitivity

When the patient does not react to the stimulus and endorses not feeling the stimulus, put the score as "Absent (0)".
When the patient reports a minor sensation in their eye, which may or may not cause them to blink, assign the score as "Reduced (1)". If using a cotton swab or tissue paper, apply slightly more pressure to touch a greater diameter of the cornea before the patient responds.
When the patient blinks when the stimulus touches the cornea or exhibits a mild reflex (e.g., gently pulls away) and indicates that they felt the stimulus, assign the score as "Normal (2)".
When the patient exhibits a hypersensitive response, reports extreme discomfort or pain, strongly pulls away from the stimulus, or even jumps out of their chair, assign the score as "Increased/hypersensitive (3)".
NOTE: Upon subsequent analysis, if the patient is found to have an unaffected eye, the response of the unaffected eye should then be used as a comparator when testing the affected eye.

4. Post-procedural steps

Dispose of the cotton wisp, dental floss, or tissue on completion of the test.
Ensure there are no infections or discomfort in the eyes.
Return for follow-up examinations as per the ophthalmologist's instructions.

Representative Results

This article aims to provide a detailed protocol for corneal sensitivity testing that is cost-effective, easy to comprehend, accessible, and can be readily adopted by eye care providers across clinical settings. The absence of corneal sensitivity results, or with no response from the patient, indicates that they did not feel the stimulus and is scored as 0. Reduced sensitivity manifests as a minimal observable response from the patient (although they may sometimes blink), in which they report barely feeling the stimulus and is scored as 1. Normal sensitivity is indicated by the patient acknowledging feeling the stimulus, blinking, and/or showing a mild reflex to pull away, and is scored as 2. Increased sensitivity manifests as a dramatic response to minor stimulation (e.g., the patient jumps up and/or indicates that the stimulus was painful or uncomfortable) and is scored as 3. Assessment of corneal sensitivity could lead to further assessments and potential diagnoses⁸^,¹²^,¹³^,³¹.

Representative results of patient case reports of clinical presentation, relevant medical history, corneal sensitivity testing, and subsequent diagnoses are presented in Table 2; patients presented with medical histories and symptoms associated with ocular surface disease. Overall, two patients were diagnosed with neurotrophic keratitis after examination and corneal sensitivity testing. Of note, these two patients also had a history of diabetes mellitus or herpes simplex infection, which are key etiologies for neurotrophic keratitis⁴⁶. Both patients presented with irritation and redness and received a score of 0 or 1 in the affected eye. Patients with a corneal sensitivity score of 2 (normal) were subsequently diagnosed with dry eye disease; patients with a corneal sensitivity score of 3 (hypersensitivity) were either diagnosed with dry eye disease or neuropathic corneal pain. Representative images of NK stages are presented in Figure 2.

Figure 1: Overview of the corneal sensitivity testing procedure. Please click here to view a larger version of this figure.

Figure 2: Stages of neurotrophic keratitis (NK). Representative images of fluorescein stain revealing superficial punctate keratopathy (stage 1 NK), persistent epithelial defect (stage 2 NK), and corneal ulcer (stage 3 NK) in individual patients with NK. Please click here to view a larger version of this figure.

Table 1: Factors supporting the decision to perform corneal sensitivity testing by ocular surface disease. Signs and symptoms supporting corneal sensitivity testing in patients with neurotrophic keratitis, neuropathic ocular pain, and dry eye disease. Please click here to download this Table.

Table 2: Summary of outcomes using qualitative corneal sensitivity testing. Representative results of patient case reports of clinical presentation, relevant medical history, corneal sensitivity testing, and subsequent diagnoses. Please click here to download this Table.

Discussion

This article described a procedure for performing corneal sensitivity testing using a qualitative method that is effective in assessing absent, reduced, normal, or increased corneal sensitivity. This procedure can be readily performed by eye care providers or physician extenders across clinical settings as it is cost-effective and accessible, requires minimal training and preparation, and can be performed quickly (approximately 30 s)⁸^,³³^,³⁷. The results are consistent across patients based on the authors' experiences⁴⁷, and the procedure can be easily incorporated into the eye care provider's workflow to support a clinical workup in patients with ocular diseases that affect the sensory corneal nerves.

As corneal sensitivity testing can be uncomfortable for the patient, it is important to test patients for whom corneal sensitivity testing would provide insight into the diagnosis of ocular surface diseases. We recommend performing corneal sensitivity testing in patients for whom there is a suspicion of ocular surface disease characterized by alterations in the corneal nerves, such as recalcitrant dry eye disease (including Sjögren's dry eye), ocular pain with neuropathic etiology, and neurotrophic keratitis. The suspicion of ocular surface disease is influenced by the patient's history and signs and symptoms⁸^,³¹^,⁴⁸.

It is essential that corneal sensitivity testing be performed prior to administration of any eye drops, particularly anesthetic eye drops, to obtain accurate results¹¹. Other factors to consider before assessing corneal sensitivity include that corneal sensitivity is greatest in the central cornea, that sensitivity decreases with older age, that the cornea is more sensitive in the periphery of elderly patients, and that corneal sensitivity is not affected by iris color⁴⁹. Varying sensitivity with age could require baseline adjustment of normal sensitivity. An additional consideration during testing arises if the suspected disease is focally located (e.g., in the superior or inferior quadrant of the eye). In this case, the testing procedure should be modified to start in the affected eye in the area of suspected disease to minimize patient discomfort and to limit testing bias. Furthermore, patients may experience a transient loss in corneal sensitivity after some surgical procedures, such as cataract surgery or LASIK, and this should be considered when evaluating corneal sensitivity results³⁰.

Corneal sensitivity scores inform the diagnosis of eye diseases characterized by alterations in the corneal nerves. For neurotrophic keratitis, reduced or absent corneal sensitivity is a key component of diagnosis¹¹^,³¹. Alterations in corneal sensitivity have been reported in dry eye disease and ocular neuropathic pain, among others³^,⁸^,¹²^,²⁴^,²⁵^,²⁶^,²⁷. However, corneal sensitivity alone is not sufficient to diagnose eye disease, and corneal sensitivity testing should be performed in conjunction with other tests to confirm the diagnosis. Notably, patients with a corneal sensitivity score within the normal range may receive a diagnosis of dry eye disease.

Limitations of the method include the qualitative nature of the assessment and the fact that corneal sensitivity testing indirectly infers the health of the corneal nerves. Alternative quantitative methods to assess corneal sensitivity are available; however, these methods have limitations, including high cost, challenges maintaining sterility, limited adoption into practice outside of a research setting, and increased time required to train personnel and conduct testing⁸^,³³^,³⁷. Quantitative methods are useful in a research setting for obtaining precise measurements of corneal sensitivity, but qualitative methods are more accessible and are generally sufficient in the clinic as part of a total clinical evaluation of a patient (e.g., medical history, clinical observations, etc.). Further studies are needed to assess the repeatability and reproducibility of qualitative corneal sensitivity testing methods and their level of agreement with quantitative methods.

In conclusion, this procedure for qualitative corneal sensitivity testing can be readily performed by eye care providers across clinical settings. Given its diagnostic value, corneal sensitivity testing should be included as part of the standard ocular surface examination for appropriate patients.

Disclosures

The authors have nothing to disclose.

Acknowledgements

Writing and editorial assistance was provided under the direction of the authors by MedThink SciCom and funded by Dompé US, Inc.

Materials

Cotton-tipped applicators	Cardinal Health	5823043	Sterile plastic shaft applicators
Cotton-tipped applicators	AMD Ritmed	1191634	Autoclave-ready nonsterile applicators
Cotton-tipped applicators	Dukai Corporation	7166142	Sterile wood shaft cotton-tipped applicators
Kimwipes	Kimberly Clark Professional	1030492	Kimwipes tissue wipes
Unwaxed dental floss	Acclean	1552880	Spool of dental floss
Unwaxed dental floss	Sunstar	7127049	6 individual packages of floss
Unwaxed dental floss	Procter & Gamble	1090833	Single-use packets of floss

References

Mastropasqua, L., Massaro-Giordano, G., Nubile, M., Sacchetti, M. Understanding the pathogenesis of neurotrophic keratitis: the role of corneal nerves. J Cell Physiol. 232 (4), 717-724 (2017).
Bonini, S., Rama, P., Olzi, D., Lambiase, A. Neurotrophic keratitis. Eye (Lond). 17 (8), 989-995 (2003).
Dua, H. S., et al. Neurotrophic keratopathy. Prog Retin Eye Res. 66, 107-131 (2018).
Labetoulle, M., et al. Role of corneal nerves in ocular surface homeostasis and disease. Acta Ophthalmol. 97 (2), 137-145 (2019).
Peterson, D. C., Hamel, R. N. . Corneal Reflex. , (2022).
Vereertbrugghen, A., Galletti, J. G. Corneal nerves and their role in dry eye pathophysiology. Exp Eye Res. 222, 109191 (2022).
Hwang, J., Dermer, H., Galor, A. Can in vivo confocal microscopy differentiate between sub-types of dry eye disease? A review. Clin Exp Ophthalmol. 49 (4), 373-387 (2021).
Sanchez, V., Cohen, N. K., Felix, E., Galor, A. Factors affecting the prevalence, severity, and characteristics of ocular surface pain. Expert Rev Ophthalmol. 18 (1), 19-32 (2023).
Craig, J. P., et al. TFOS DEWS II definition and classification report. Ocul Surf. 15 (3), 276-283 (2017).
Guerrero-Moreno, A., Baudouin, C., Melik Parsadaniantz, S., Réaux-Le Goazigo, A. Morphological and functional changes of corneal nerves and their contribution to peripheral and central sensory abnormalities. Front Cell Neurosci. 14, 610342 (2020).
Neurotrophic Keratopathy Study Group. Neurotrophic keratopathy: An updated understanding. Ocul Surf. 30, 129-138 (2023).
Ahuja, Y., Baratz, K. H., McLaren, J. W., Bourne, W. M., Patel, S. V. Decreased corneal sensitivity and abnormal corneal nerves in Fuchs endothelial dystrophy. Cornea. 31 (11), 1257-1263 (2012).
Patel, S., Hwang, J., Mehra, D., Galor, A. Corneal nerve abnormalities in ocular and systemic diseases. Exp Eye Res. 202, 108284 (2021).
Sherwin, T., Brookes, N. H. Morphological changes in keratoconus: Pathology or pathogenesis. Clin Exp Ophthalmol. 32, 211-217 (2004).
Priyadarsini, S., et al. Diabetic keratopathy: Insights and challenges. Surv Ophthalmol. 65 (5), 513-529 (2020).
Stepp, M. A., et al. Reduced intraepithelial corneal nerve density and sensitivity accompany desiccating stress and aging in C57BL/6 mice. Exp Eye Res. 169, 91-98 (2018).
Vereertbrugghen, A., et al. An ocular Th1 immune response promotes corneal nerve damage independently of the development of corneal epitheliopathy. J Neuroinflammation. 20 (1), 120 (2023).
Ebrahimiadib, N., Yousefshahi, F., Abdi, P., Ghahari, M., Modjtahedi, B. S. Ocular neuropathic pain: An overview focusing on ocular surface pains. Clin Ophthalmol. 14, 2843-2854 (2020).
Belmonte, C., Acosta, M. C., Schmelz, M., Gallar, J. Measurement of corneal sensitivity to mechanical and chemical stimulation with a CO2 esthesiometer. Invest Ophthalmol Vis Sci. 40 (2), 513-519 (1999).
Pedrotti, E., et al. Eight months follow-up of corneal nerves and sensitivity after treatment with cenegermin for neurotrophic keratopathy. Orphanet J Rare Dis. 17 (1), 63 (2022).
Wu, Y., et al. Clinical outcomes of minimally invasive corneal neurotization after cerebellopontine angle neurosurgical procedures. Curr Eye Res. 47 (5), 670-676 (2022).
Posarelli, M., et al. Corneal nerve regeneration is affected by scar location in herpes simplex keratitis: A longitudinal in vivo confocal microscopy study. Ocul Surf. 28, 42-52 (2023).
Labbé, A., et al. The relationship between subbasal nerve morphology and corneal sensation in ocular surface disease. Invest Ophthalmol Vis Sci. 53 (8), 4926-4931 (2012).
Lee, Y., Kim, M., Galor, A. Beyond dry eye: How co-morbidities influence disease phenotype in dry eye disease. Clin Exp Optom. 105 (2), 177-185 (2022).
Terai, N., Müller-Holz, M., Spoerl, E., Pillunat, L. E. Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects. Clin Ophthalmol. 5, 517-525 (2011).
Chadha, N., Belyea, D. A., Grewal, S. Herpetic stromal keratitis following selective laser trabeculoplasty. Case Rep Ophthalmol Med. 2016, 5768524 (2016).
Perez, C. I., Han, Y., Rose-Nussbaumer, J., Ou, Y., Hsia, Y. C. Neurotrophic keratitis after micropulse transscleral diode laser cyclophotocoagulation. Am J Ophthalmol Case Rep. 15, 100469 (2019).
Sayed, M. S., Khodeiry, M. M., Elhusseiny, A. M., Sabater, A. L., Lee, R. K. Neurotrophic keratopathy after slow coagulation transscleral cyclophotocoagulation. Cornea. 42 (12), 1582-1585 (2023).
De Paiva, C. S., Pflugfelder, S. C. Corneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulation. Am J Ophthalmol. 137 (1), 109-115 (2004).
Yang, A. Y., Chow, J., Liu, J. Corneal innervation and sensation: the eye and beyond. Yale J Biol Med. 91 (1), 13-21 (2018).
Dana, R., et al. Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy. BMC Ophthalmol. 21 (1), 327 (2021).
Belmonte, C., et al. TFOS DEWS II pain and sensation report. Ocul Surf. 15 (3), 404-437 (2017).
Milner, M. S., et al. Dysfunctional tear syndrome: Dry eye disease and associated tear film disorders – new strategies for diagnosis and treatment. Curr Opin Ophthalmol. 27 (suppl 1), 3-47 (2017).
Faulkner, W. J., Varley, G. A., Krachmer, J. H., Mannis, M. J., Holland, E. J. Corneal diagnostic techniques. Cornea: Fundamentals of Cornea and External Disease. 1, 275-281 (1996).
Sacchetti, M., Lambiase, A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 8, 571-579 (2014).
Merayo-Lloves, J., et al. Corneal sensitivity with non-contact air jet esthesiometry compared with mechanical esthesiometry. Invest Ophthalmol Vis Sci. 63 (7), 1201-A0201 (2022).
Patel, S., Mehra, D., Cabrera, K., Galor, A. How should corneal nerves be incorporated into the diagnosis and management of dry eye. Curr Ophthalmol Rep. 9 (3), 65-76 (2021).
Golebiowski, B., Papas, E., Stapleton, F. Assessing the sensory function of the ocular surface: Implications of use of a non-contact air jet aesthesiometer versus the Cochet-Bonnet aesthesiometer. Exp Eye Res. 92 (5), 408-413 (2011).
. Corneal Esthesiometer Brill. Instructions for use Available from: https://brillengines.com/wp-content/uploads/2024/04/231122_IFUestesiometro_EN2.pdf (2023)
Moshirfar, M., Benstead, E. E., Sorrentino, P. M., Tripathy, K. . Ocular Neuropathic Pain. , (2023).
Patel, S., Mittal, R., Sarantopoulos, K. D., Galor, A. Neuropathic ocular surface pain: Emerging drug targets and therapeutic implications. Expert Opin Ther Targets. 26 (8), 681-695 (2022).
Dry Eye syndrome questionnaires. Available from: https://eyewiki.aao.org/Dry_Eye_Syndrome_Questionnaires (2023)
NaPier, E., Camacho, M., McDevitt, T. F., Sweeney, A. R. Neurotrophic keratopathy: Current challenges and future prospects. Ann Med. 54 (1), 666-673 (2022).
Millodot, M., Eskridge, J. B., Amos, J. F., Bartlett, J. D. . Clinical Procedures in Optometry. , (1991).
American Academy of Ophthalmology. Chapter 2: Examination Techniques for the External Eye and Cornea Available from: https://www.aao.org/education/bcscsnippetdetail.aspx?id=dd3cc217-5e32-438d-b269-05044fae9a73 (2021)
Bian, Y., et al. Neurotrophic keratopathy in the United States: An intelligent research in sight registry analysis. Ophthalmology. 129 (11), 1255-1262 (2022).
Managing the painful eye with underwhelming findings. Ophthalmology Management Available from: https://www.ophthalmologymanagement.com/newsletters/the-cornea-and-ocular-surface/september-2021 (2021)
Zeev, M. S. -. B., Miller, D. D., Latkany, R. Diagnosis of dry eye disease and emerging technologies. Clin Ophthalmol. 8, 581-590 (2014).
Rocha, K. M. Diagnostic clues: Thorough history-taking and confirmatory testing reveal neurotrophic keratitis. CRS Today. 2020, 7-9 (2020).

Play Video

PDF

DOI

DOWNLOAD MATERIALS LIST

Cite This Article

Galor, A., Lighthizer, N. Corneal Sensitivity Testing Procedure for Ophthalmologic and Optometric Patients. J. Vis. Exp. (210), e66597, doi:10.3791/66597 (2024).